BRVE SCHEDULE 13D: SEC filing
OrbiMed Advisors LLC and affiliated entities
Filed with the SEC on · accession 0000947871-26-000814
BRVE filed a SCHEDULE 13D (schedule 13d) with the SEC on Aug 18, 2026. OrbiMed Advisors LLC and affiliated entities filed a joint filing agreement as part of a Schedule 13D regarding their position in Braveheart Bio, Inc. common stock. The stock moved -3.3% by the first close after the filing.
Summary of the filing
OrbiMed Advisors LLC and affiliated entities filed a joint filing agreement as part of a Schedule 13D regarding their position in Braveheart Bio, Inc. common stock. The agreement confirms the filing is made jointly on behalf of all undersigned parties.
Key details
How BRVE stock reacted
Close before
$27.66
Aug 17, 2026
First close after
-3.29%
$26.75
5 trading days
-0.58%
$27.50
Since filing
-32.75%
$18.60
✦ Ask GOAX AI about this filing — what it means for BRVE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BRVE?
Click hereFrequently asked questions
What did BRVE file with the SEC on Aug 18, 2026?
BRVE filed a SCHEDULE 13D (SEC filing). OrbiMed Advisors LLC and affiliated entities filed a joint filing agreement as part of a Schedule 13D regarding their position in Braveheart Bio, Inc. common stock. The agreement confirms the filing is made jointly on behalf of all undersigned parties.
How do I read a SCHEDULE 13D?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D (schedule 13d): A report the company filed with the SEC (the US market regulator).
How did BRVE stock react to this filing?
BRVE closed at $27.66 before the filing and $26.75 on Aug 18, 2026 (-3.29%). Five trading days later: $27.50 (-0.58%).
Other BRVE SEC filings
Get alerts when BRVE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days